Clovis Oncology News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

08.05.18	Clovis Oncology Announces First Quarter 2018 Operating Results (Businesswire)
24.04.18	Clovis Oncology to Announce First Quarter 2018 Financial Results and Host Webcast Conference Call on May 8 (Businesswire)
17.04.18	Clovis Oncology Announces Pricing of Public Offerings of Convertible Senior Notes and Common Stock (Businesswire)
16.04.18	Clovis Oncology Announces Proposed Offerings of Convertible Senior Notes and Common Stock (Businesswire)
06.04.18	Rubraca® (rucaparib) Approved in the U.S. as Maintenance Treatment of Recurrent Ovarian Cancer (Businesswire)
01.04.18	An Ear To The Pharma: 5 Stocks To Watch This Week (RTTNews)
28.03.18	Biotech Stocks Facing FDA Decision In April (RTTNews)
26.03.18	CHMP Says Yes To CLVS, No To PTLA, NVCN Put On Notice, OGEN To Report Data In Q2 (RTTNews)
23.03.18	Clovis Oncology Initiates Early Access Program for Rucaparib as Treatment and as Maintenance Therapy in Recurrent Ovarian Cancer in Europe (Businesswire)
23.03.18	CHMP Grants Positive Opinion for Clovis Oncology’s Rubraca® (rucaparib) Tablets (Businesswire)
08.03.18	Clovis Oncology Announces Notice of Allowance for Rucaparib High Dosage Strength Tablet Patent with Expiration in 2035 (Businesswire)
07.03.18	Clovis Oncology to Present at the Barclays Global Healthcare Conference (Businesswire)
22.02.18	ACIP Backs HEPLISAV-B, GMED Hits New High, GWPH's Focal Seizures Trial Fails (RTTNews)
12.02.18	Clovis Oncology to Announce Fourth Quarter and Full Year 2017 Financial Results and Host Webcast Conference Call on February 26 (Businesswire)
04.01.18	Clovis Oncology to Present at the 36th Annual J.P. Morgan Healthcare Conference (Businesswire)
19.12.17	Rucaparib MAA for the Ovarian Cancer Treatment Indication Referred by CHMP to Scientific Advisory Group on Oncology for Review Expected in February 2018 (Businesswire)
06.12.17	NVO Gets FDA Nod, GALT Down But Not Out, BIOC Gets A Boost, CUR Excited (RTTNews)
05.12.17	Clovis Announces Priority Review Designation for Rucaparib Supplemental New Drug Application (Businesswire)
09.11.17	Clovis Oncology to Present at the Stifel 2017 Healthcare Conference (Businesswire)
01.11.17	Clovis Oncology Announces Third Quarter 2017 Operating Results (Businesswire)
10.10.17	CLVS Seeks New Use For Rubraca, TNDM Effects Reverse Stock Split, MDXG On Watch (RTTNews)
19.09.17	NBRV Leaps On Study Data, CSII Takes A Hit, CLVS Abuzz, New Dimension For DMTX (RTTNews)
15.09.17	Biotech Stocks on Investors' Radar -- Clovis Oncology, Dermira, Editas Medicine, and Endocyte (PR Newswire)
13.09.17	Clovis Oncology’s Rucaparib ARIEL3 Study Data Published in The Lancet (Businesswire)
08.09.17	Clovis Oncology Presents Comprehensive Dataset from Successful Phase 3 ARIEL3 Maintenance Treatment Trial of Rucaparib in Advanced Ovarian Cancer at ESMO 2017 (Businesswire)
01.08.17	Gainers & Losers Of July 31: SBBP, AKCA, ACRX, ICPT, ZYNE... (RTTNews)
24.07.17	Technical Snapshots for These Biotech Stocks -- Exelixis, Celldex Therapeutics, Clovis Oncology, and Geron (PR Newswire)
21.06.17	Biopharma Stock Breakouts With Significant Developments and Market Activity (PR Newswire)
21.06.17	Biopharma Stock Breakouts With Significant Developments and Market Activity (PR Newswire)
21.06.17	Key Pharma Stocks With Advanced Developments and Breakthrough Discoveries (PR Newswire)
21.06.17	Key Pharma Stocks With Advanced Developments and Breakthrough Discoveries (PR Newswire)
20.06.17	AMGN's Xgeva To Face FDA In Feb, Double Treat For LPCN, SGEN Drops Cascade (RTTNews)
20.06.17	Gainers & Losers Of June 19: ARNA, NVDQ, CLVS, RWLK, CLSN... (RTTNews)
07.04.17	Muskingum University Installs Dr. Susan S. Hasseler As Its 21st President (PR Newswire)
07.04.17	Research Reports Initiation on Biotech Stocks -- Sarepta Therapeutics, Galena Biopharma, Anthera Pharma, and Clovis Oncology (PR Newswire)
06.04.17	Global Oncology Market Gains Ground, Driven by Innovative Cancer Treatment Therapies (PR Newswire)
17.03.17	5 Biotech Companies Set for Major Breakouts in 2017 (PR Newswire)
15.03.17	Gainers & Losers Of Mar.14: CVRS, OCX, OFIX, PETX, AMPH... (RTTNews)
21.02.17	Biotech Stocks under Scanner -- ACADIA Pharma, Clovis Oncology, Galena Biopharma, and Northwest Biotherapeutics (PR Newswire)
13.01.17	Technical Reports on Biotech Stocks -- Clovis Oncology, Galena Biopharma, and ACADIA Pharma (PR Newswire)
13.01.17	Gainers & Losers Of The Day: TBIO, IMMU, SGMO, BIOC, APRI (RTTNews)
20.12.16	CLVS Gets FDA Nod, PBYI Leaves Big Board, LOXO Hits All-time High, CNAT On Watch (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’406.50	1.48 %	K V
Swiss Life Hldg	764.20	1.16 %	K V
Kuehne+Nagel Int	203.80	1.14 %	K V
Logitech Intl	91.02	0.91 %	K V
ABB	50.08	0.81 %	K V
Nestle	77.36	-0.18 %	K V
Swisscom	526.00	-0.19 %	K V
UBS Group	30.31	-0.36 %	K V
Givaudan	3’828.00	-0.57 %	K V
Alcon	81.70	-0.73 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Clovis Oncology Inc.

Aktien Top/Flop

Meistgelesene Nachrichten